HIMS - NYSE
Hims & Hers Health, Inc.
$27.51
+3.5%Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
At a Glance
Live Snapshothims
Total Assets
Last Annual Value
2.15B
3-Year CAGR
81%
5-Year CAGR
79%
10-Year CAGR
40%
Hims & Hers Health, Inc. Competitors Analysis of Total Assets
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Hims & Hers Health, Inc. NYSE:HIMS | 2.15B | 69.7% | 38.6% | N/A | |
 BioMarin Pharmaceutical Inc. NASDAQ:BMRN | 7.59B | 3.5% | 4.8% | 6.6% | |
 Baxter International Inc. NYSE:BAX | 20.05B | -10.8% | -9.8% | 2.6% | |
 Revvity, Inc. NYSE:RVTY | 12.17B | -3.6% | -4.1% | 11.0% | |
 Penumbra, Inc. NYSE:PEN | 1.83B | 5.5% | 8.0% | 19.5% | |
 Qiagen N.V. NYSE:QGEN | 6.30B | 1.0% | 0.5% | 3.9% | |
 The Ensign Group, Inc. NASDAQ:ENSG | 5.46B | 9.4% | 13.9% | 18.5% | |
 Bio-Techne Corporation NASDAQ:TECH | 2.56B | -1.0% | 2.5% | 8.5% | |
 Align Technology, Inc. NASDAQ:ALGN | 6.23B | 0.8% | 1.0% | 16.1% | |
 Moderna, Inc. NASDAQ:MRNA | 12.34B | -12.5% | -12.9% | 24.2% | |
 HealthEquity, Inc. NASDAQ:HQY | 3.43B | 3.6% | 4.8% | 31.6% |
Hims & Hers Health, Inc. Fair Value Envelope
Related Guides
Continue your HIMS research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.